In the subgroup of AA amyloidosis patients with glomerular filtration rate (GFR) > 20 mL/min at baseline, renal survival was significantly impaired if median SAA levels reached 28 mg/L (p < 0.001, by the Kruskal–Wallis test). The gene discussed is SAA1; the disease is AA amyloidosis.